Doubling down on deep customer insights to inform value demonstration

An Expert View from Ross Maclean, Precision Health Economics, Outcomes Research and Head of Medical Affairs,
Precision Value and Health, and the same company's Jon Bambalas, Senior Vice President Business Development, Products Senior Vice President Business Development.

With more than 10 government agencies and at least 100 commercial health insurers/PBMs providing different types of health insurance and drug coverage for Americans, the potential for confusion on what policy covers is obvious. Pity the over-worked clinic administrator or provider who cannot recall which health plan covers which test, referral, procedure, or drug that the patient needs!

Insights from patient-level health insurance benefits data can serve the pharmaceutical industry – namely, how coverage insights can inform the generation of evidence to demonstrate to payers and providers the value of a specific treatment.